1. Certain ophthalmic products: policy regarding compliance with 21 CFR part 4 Publication: Silver Spring, MD : Center for Drug Evaluation and Research, March 2022 Subject(s): Administration, OphthalmicEquipment and SuppliesUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
